D
Depixus SAS, based in Paris, is a life science technology company pioneering a groundbreaking technology based on magnetic force spectroscopy. This innovative technology provides real-time analysis of individual biomolecular interactions at scale, enabling researchers to decode disease mechanisms and unlock faster routes to more effective therapies.
Investor insights
Funding rounds participated in
$35M sweet spot round size
Investor type
Privately Held
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Funding rounds raised
Total raised
$35M
from 3 investors over 1 rounds
D
Depixus raised $35M on January 15, 2022
Investors: Bpifrance, Lansdowne Partners and + 2 Other investors